#Obesity #WeightLoss #DiabetesResearch #GLP1RA sciencedirect.com/science/articl Join the conversation
It uses the same active ingredient as injectable Wegovy, but it is a different product and would require its own EU application and approval before routine Irish supply
The difference often depends on whether specific beneficial bacteria are supported during this transition Tirzepatide and Zepbound Gut Side Effects Tirzepatide is the active ingredient in Mounjaro, prescribed for type 2 diabetes, and Zepbound, prescribed for chronic weight management
Valproate-induced hepatotoxicity In up to 44% of patients chronic dosing with VPA may be associated with elevation in transaminases [23] during the first months of therapy
Additionally, while clinical guidelines for indicated use of GLP-1 RAs are rapidly changing as evidence for GLP-1 RA use evolves, the ethics of off-label use are particularly important to consider given the impact these shortages can have on access for patients who otherwise have a strong clinical indication to be on them
Efficacy and safety of lixisenatide once daily vs
